Accounts Payable - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Accounts Payable Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Accounts Payable
ÂŁ14.2B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
7%
A
AstraZeneca PLC
NASDAQ:AZN
Accounts Payable
$20.5B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
7%
Indivior PLC
LSE:INDV
Accounts Payable
$46m
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
-1%
Hikma Pharmaceuticals PLC
LSE:HIK
Accounts Payable
$541m
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
16%
Allergy Therapeutics PLC
LSE:AGY
Accounts Payable
ÂŁ20.1m
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
12%
Dechra Pharmaceuticals PLC
LSE:DPH
Accounts Payable
ÂŁ144.5m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
18%

See Also

What is GlaxoSmithKline PLC's Accounts Payable?
Accounts Payable
14.2B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Accounts Payable amounts to 14.2B GBP.

What is GlaxoSmithKline PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
7%

Over the last year, the Accounts Payable growth was 2%.

Back to Top